Though RBC Capital’s Ross MacMillan bets on a 4Q earnings outclass come Thursday, SHOP’s valuation keeps him playing it safe.
FBR’s Eric Wold spotlights a box office tailwind ahead thanks to MoviePass’ rocket-fire momentum in attracting subscribers to theaters.
BTIG’s Tim Chiang is out with a bearish case against Teva after last week’s less-than-stellar 2018 guidance reveal.
GBH Insights’ analyst Daniel Ives sees all the reasons to feel frustrated with Apple’s recent challenges- but likes the risk/reward all the same.
While Snap surpassed the Street’s expectations for Q4, Wedbush’s Michael Pachter remains unconvinced.
Pivotal’s Brian Wieser chimes in apprehensive on Alphabet, but 4Q print has left him a bit more positive on long-term expectations.
Canaccord’s Michael Graham now angles for 27% return potential for FB stock on back of an “impressive” quarterly print.
We are on the brink of seeing the fourth quarter earning results for two very interesting stocks namely: Advanced Micro Devices, Inc. (NASDAQ:AMD) …
With its stock trading near a 52-week high, Amarin Corporation plc (ADR) (NASDAQ:AMRN) is cashing out at the top. On Monday, Amarin announced …
Bulls get ready, because Susquehanna analyst Christopher Rolland angles for a meaningful fourth quarter earnings beat from Advanced Micro Devices, Inc. (NASDAQ:AMD) once …
